# Macrogenics Inc: filings

MGNX · Nasdaq · CIK 1125345 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgnx.md) · [Financials](/companies/mgnx/financials.md) · [Filings](/companies/mgnx/filings.md) · [Insiders](/companies/mgnx/insiders.md)

## Reports and events: 224 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 433, 8-K 147, SC 13G/A 60, 10-Q 39, 3 32, SC 13G 27, 144 17, SCHEDULE 13G/A 17, S-8 15, 10-K 13, DEF 14A 13, UPLOAD 13, CORRESP 11, CT ORDER 11, DEFA14A 11, 424B5 10, 4/A 9, 5 6, EFFECT 6, S-1/A 6, SCHEDULE 13G 5, S-3 3, 10-K/A 2, 424B4 2, 8-K/A 2, ARS 2, S-1 2, S-3ASR 2, 424B3 1, 8-A12B 1, CERTNAS 1, D 1, DRS 1, POS AM 1, POSASR 1, PRE 14A 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 20:05 ET | [8-K](/filings/0001125345-26-000066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-26-000066 |
| 2026-09-03 | 20:39 ET | [8-K/A](/filings/0001125345-26-000059.md) | 9.01 Financial statements and exhibits | 0001125345-26-000059 |
| 2026-08-14 | 20:19 ET | [10-Q](/filings/0001125345-26-000056.md) | Quarterly report, period 2026-06-30 | 0001125345-26-000056 |
| 2026-08-13 | 20:07 ET | [8-K](/filings/0001125345-26-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-26-000054 |
| 2026-07-23 | 20:07 ET | [8-K](/filings/0001125345-26-000050.md) | 8.01 Other events | 0001125345-26-000050 |
| 2026-07-08 | 20:00 ET | [8-K](/filings/0001125345-26-000047.md) | 5.02 Departure or appointment of officers or directors | 0001125345-26-000047 |
| 2026-07-07 | 20:30 ET | [8-K](/filings/0001125345-26-000045.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-26-000045 |
| 2026-05-20 | 20:01 ET | [8-K](/filings/0001125345-26-000042.md) | 5.07 Shareholder vote results | 0001125345-26-000042 |
| 2026-05-13 | 20:22 ET | [8-K](/filings/0001125345-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-26-000040 |
| 2026-05-13 | 20:13 ET | [10-Q](/filings/0001125345-26-000038.md) | Quarterly report, period 2026-03-31 | 0001125345-26-000038 |
| 2026-05-12 | 12:00 ET | [8-K](/filings/0001125345-26-000035.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-26-000035 |
| 2026-05-04 | 20:02 ET | [8-K](/filings/0001125345-26-000032.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-26-000032 |
| 2026-04-08 | 20:41 ET | [8-K](/filings/0001125345-26-000026.md) | 8.01 Other events | 0001125345-26-000026 |
| 2026-04-08 | 20:01 ET | [DEF 14A](/filings/0001125345-26-000021.md) | Proxy statement, period 2026-05-19 | 0001125345-26-000021 |
| 2026-03-09 | 20:12 ET | [8-K](/filings/0001125345-26-000018.md) | 2.02 Results of operations | 0001125345-26-000018 |
| 2026-03-09 | 20:10 ET | [10-K](/filings/0001125345-26-000017.md) | Annual report, period 2025-12-31 | 0001125345-26-000017 |
| 2026-03-02 | 21:15 ET | [8-K](/filings/0001125345-26-000011.md) | 8.01 Other events | 0001125345-26-000011 |
| 2026-02-24 | 23:41 ET | [8-K](/filings/0001125345-26-000009.md) | 8.01 Other events | 0001125345-26-000009 |
| 2025-11-20 | 21:01 ET | [8-K](/filings/0001125345-25-000111.md) | 5.02 Departure or appointment of officers or directors | 0001125345-25-000111 |
| 2025-11-12 | 21:04 ET | [8-K](/filings/0001125345-25-000109.md) | 2.02 Results of operations | 0001125345-25-000109 |
| 2025-11-12 | 21:04 ET | [10-Q](/filings/0001125345-25-000108.md) | Quarterly report, period 2025-09-30 | 0001125345-25-000108 |
| 2025-08-14 | 20:06 ET | [10-Q](/filings/0001125345-25-000101.md) | Quarterly report, period 2025-06-30 | 0001125345-25-000101 |
| 2025-08-14 | 20:04 ET | [8-K](/filings/0001125345-25-000100.md) | 2.02 Results of operations | 0001125345-25-000100 |
| 2025-08-13 | 20:14 ET | [8-K](/filings/0001125345-25-000094.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-25-000094 |
| 2025-06-10 | 11:02 ET | [8-K](/filings/0001125345-25-000087.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-25-000087 |
| 2025-05-22 | 20:00 ET | [8-K](/filings/0001125345-25-000075.md) | 5.07 Shareholder vote results | 0001125345-25-000075 |
| 2025-05-13 | 20:02 ET | [8-K](/filings/0001125345-25-000054.md) | 2.02 Results of operations | 0001125345-25-000054 |
| 2025-05-13 | 20:01 ET | [10-Q](/filings/0001125345-25-000053.md) | Quarterly report, period 2025-03-31 | 0001125345-25-000053 |
| 2025-04-11 | 20:00 ET | [DEF 14A](/filings/0001125345-25-000047.md) | Proxy statement, period 2025-05-21 | 0001125345-25-000047 |
| 2025-03-20 | 20:05 ET | [8-K](/filings/0001125345-25-000043.md) | 2.02 Results of operations | 0001125345-25-000043 |
| 2025-03-20 | 20:05 ET | [10-K](/filings/0001125345-25-000042.md) | Annual report, period 2024-12-31 | 0001125345-25-000042 |
| 2025-02-26 | 22:11 ET | [8-K](/filings/0001193125-25-036898.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-036898 |
| 2024-11-21 | 21:32 ET | [8-K](/filings/0001125345-24-000165.md) | 5.02 Departure or appointment of officers or directors | 0001125345-24-000165 |
| 2024-11-05 | 21:03 ET | [8-K](/filings/0001125345-24-000161.md) | 2.02 Results of operations | 0001125345-24-000161 |
| 2024-11-05 | 21:02 ET | [10-Q](/filings/0001125345-24-000160.md) | Quarterly report, period 2024-09-30 | 0001125345-24-000160 |
| 2024-10-30 | 11:40 ET | [8-K](/filings/0001193125-24-247017.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-247017 |
| 2024-09-16 | 20:02 ET | [8-K](/filings/0001125345-24-000151.md) | 8.01 Other events | 0001125345-24-000151 |
| 2024-08-06 | 20:02 ET | [8-K](/filings/0001125345-24-000149.md) | 2.02 Results of operations | 0001125345-24-000149 |
| 2024-08-06 | 20:01 ET | [10-Q](/filings/0001125345-24-000148.md) | Quarterly report, period 2024-06-30 | 0001125345-24-000148 |
| 2024-07-30 | 20:18 ET | [8-K](/filings/0001125345-24-000141.md) | 8.01 Other events | 0001125345-24-000141 |
| 2024-07-30 | 20:08 ET | [8-K](/filings/0001125345-24-000140.md) | 8.01 Other events | 0001125345-24-000140 |
| 2024-05-23 | 20:24 ET | [8-K](/filings/0001125345-24-000124.md) | 5.07 Shareholder vote results | 0001125345-24-000124 |
| 2024-05-09 | 20:06 ET | [8-K](/filings/0001125345-24-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-24-000091 |
| 2024-05-09 | 20:05 ET | [8-K](/filings/0001125345-24-000090.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-24-000090 |
| 2024-05-09 | 20:02 ET | [10-Q](/filings/0001125345-24-000088.md) | Quarterly report, period 2024-03-31 | 0001125345-24-000088 |
| 2024-04-08 | 20:31 ET | [DEF 14A](/filings/0001125345-24-000076.md) | Proxy statement, period 2024-05-21 | 0001125345-24-000076 |
| 2024-04-03 | 21:24 ET | [8-K](/filings/0001125345-24-000065.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-24-000065 |
| 2024-03-07 | 21:04 ET | [8-K](/filings/0001125345-24-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-24-000061 |
| 2024-03-07 | 21:03 ET | [10-K](/filings/0001125345-24-000060.md) | Annual report, period 2023-12-31 | 0001125345-24-000060 |
| 2023-11-06 | 21:04 ET | [8-K](/filings/0001125345-23-000125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-23-000125 |

Page 1 of 5. [Older](/companies/mgnx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.